• Executive interview - Race Oncology

    850 views 2 years ago
    Race Oncology is developing bisantrene, which had been the subject of over 40 clinical trials in the 1980s and 1990s as part of Lederle’s search for a safer anthracycline chemotherapy. Despite positive responses in a variety of cancers, especially AML (it was even approved for the treatment of AML in France, but never commercialised), development stopped after Lederle was sold to Wyeth and then Wyeth to Pfizer. Race will be developing bisantrene initially for relapsed/refractory AML and expects to start a pivotal trial for approval in the US around the end of 2018. Show less
    Read more
  • Uploads Play all

    • Executive interview – Applied Graphene Materials - Duration: 12 minutes, 27 seconds.

      • 1 day ago
      Adrian Potts, the CEO of Applied Graphene Materials (AGM), discusses the company’s commercial progress over the course of the past 12 months, which saw the launch of a number of coatings products b...
    • Executive interview – WANdisco - Duration: 10 minutes, 21 seconds.

      • 5 days ago
      WANdisco recently confirmed that its Fusion product is on track for full availability with Microsoft ‘in the next few weeks’. In this audio clip CEO David Richards describes the commercial implicat...
    • Executive interview - Boku - Duration: 12 minutes, 56 seconds.

      • 5 days ago
      Boku has developed and operates a platform that connects mobile carriers with merchants. This supports direct carrier billing (DCB), which serves as an alternative payment method for companies sell...
    • Executive interview - EMIS Group - Duration: 13 minutes, 11 seconds.

      • 1 week ago
      EMIS Group is a clinical software supplier to the UK healthcare market. The company was originally established to serve the GP market, where it has a leading position with a market share of 57% of ...
    • Executive interview - Basilea Pharmaceutica - Duration: 3 minutes, 7 seconds.

      • 2 weeks ago
      Basilea Pharmaceutica is a Switzerland-based biopharmaceutical company, established in 2000 as a spin-out from Roche with the divestment of its anti-infective portfolio. Basilea was listed on the S...
    • Executive interview – Seneca Income & Growth Trust - Duration: 6 minutes, 28 seconds.

      • 2 weeks ago
      Seneca Global Income & Growth Trust (LSE:SIGT) was launched in 2005 and adopts a multi-asset value investing approach, aiming to generate income and capital growth with low volatility by investing ...
    • Executive interview - Gresham Technologies - Duration: 8 minutes, 35 seconds.

      • 2 weeks ago
      Ian Manocha, CEO of Gresham Technologies, discusses the company’s transition towards a pure subscription software model centred on Clareti, Gresham’s next generation data integrity software platfor...
    • Executive interview – XP Power FY19 results - Duration: 8 minutes, 47 seconds.

      • 4 weeks ago
      In this interview, CEO Duncan Penny and CFO Gavin Griggs discuss XP Power’s FY19 results. Duncan discusses the performance by sector, highlighting that demand from the industrial, technology and he...
    • Executive interview - Diginex - Duration: 7 minutes, 22 seconds.

      • 4 weeks ago
      Diginex is a digital financial services and blockchain solutions company. The company was founded in 2017 by Miles Pelham (Chairman). Diginex operates through three business lines: Solutions, Marke...
    • Executive interview – VolitionRx - Duration: 7 minutes, 16 seconds.

      • 1 month ago
      VolitionRx is a multinational epigenetics company developing simple, easy-to-use, cost-effective blood tests to help diagnose a range of cancers and other diseases. Early diagnosis has the potentia...
    • Bitesize briefing – Renergen - Duration: 11 minutes, 17 seconds.

      • 1 month ago
      In this video Ian McLelland discusses his visit to Renergen’s facilities in the Free State, South Africa in early February. The visit took in Renergen’s gas processing facilities, ongoing drilling ...
    • Executive interview – Treatt - Duration: 8 minutes, 35 seconds.

      • 1 month ago
      Treatt’s clean-label innovations continue to resonate with consumer demand for better-for-you/natural products, as consumers continue to look for premium beverage propositions with positive health ...
    This item has been hidden
  • This item has been hidden
to add this to Watch Later

Add to

Loading playlists...